GSK
Gsk Plc-spon Adr.
$40.59
Earnings Summary
Revenue | $8052Mn |
Net Profits | $350Mn |
Net Profit Margins | 4.35% |
PE Ratio | 13.29 |
Highlights
Gsk Plc-spon Adr.’s revenue jumped 9.16% since last year same period to $8052Mn in the Q4 2023. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -1.17% fall in its revenue since last 3-months.
Gsk Plc-spon Adr.’s net profit fell -76.04% since last year same period to $350Mn in the Q4 2023. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -76.09% fall in its net profits since last 3-months.
Gsk Plc-spon Adr.’s net profit margin fell -78.06% since last year same period to 4.35% in the Q4 2023. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -75.81% fall in its net profit margins since last 3-months.
Gsk Plc-spon Adr.’s price-to-earnings ratio after this Q4 2023 earnings stands at 13.29.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Gsk Plc-spon Adr. post its latest quarter earnings
EPS Estimate Current Quarter | 0.92 |
EPS Estimate Current Year | 0.92 |
Highlights
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 0.92 - a 21.62% jump from last quarter’s estimates.
Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 0.92.
Key Ratios
Key ratios of the Gsk Plc-spon Adr. post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.41 |
Highlights
Gsk Plc-spon Adr.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Gsk Plc-spon Adr. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Gsk Plc-spon Adr. declared 0.41 dividend per share during the earnings announcement for Q1 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-01 | 0.92 | 0 | -100% |
₹0 US Stocks a/c Opening Fee